Novo Nordisk chair and six directors exit after dispute with shareholder

Novo Nordisk chair and six directors exit after dispute with shareholder

Danish drugmaker grapples with slowing growth and falling share price

Leave a Reply

Your email address will not be published. Required fields are marked *

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support
WordPress Cookie Plugin by Real Cookie Banner